Table 3.
Receiving Operating Characteristics (ROC) Curve Analysis to Evaluate the Diagnostic Accuracy of Select Biochemical Tests and Clinical Markers for the Diagnosis of Hyperandrogenic Anovulation
Biochemical Test or Clinical Marker | Area under the ROC curve | 95% Confidence Interval | Inflection Point of Greatest Sensitivity and Specificity (sensitivity, specificity) |
---|---|---|---|
Testosterone | 0.689 | 0.686–0.923 | 73.4 (0.632, 0.750) |
1/SHBG | 0.917 | 0.852–0.983 | 1.2 (0.864, 0.854) |
FAI | 0.887 | 0.867–0.991 | 6.0 (0.842, 0.778) |
Δ 4A | 0.743 | 0.602–0.884 | 339 (0.667, 0.805) |
LH | 0.763 | 0.630–0.896 | 6.2 (0.727, 0.707) |
LH: FSH Ratio | 0.748 | 0.610–0.887 | 1.2 (0.818, 0.293) |
1/GIR | 0.776 | 0.639–0.913 | 5.3 (0.818, 0.690) |
Clitoral Index | 0.782 | 0.659–0.905 | 24.5 (0.714, 0.707) |
Age at Menarche | 0.583 | 0.425–0.741 | 11.5 (0.545, 0.548) |
Waist Circumference | 0.897 | 0.815–0.979 | 75.25 (0.864, 0.857) |
Waist Circumference* | 0.824 | 0.717–0.931 | 77.75 (0.786, 0.714) |
BMI* | 0.839 | 0.739–0.939 | 27.0 (0.786, 0.730) |
ROC curves were generated using redefined physical exam criteria with overweight and acanthosis nigricans removed from prospective physical exam criteria.